Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.
Respiratory · Respir Med · 2026-10-14
RCTn = 63
Kadura et al. Yoga effect on quality of life study among patients with idiopathic pulmonary fibrosis (YES-IPF)Respiratory · Eur Respir J · 2026-10-09
RCTn = 51
Salazar-Pérez et al. Home-based, remotely supervised, high-intensity interval training and cardiorespiratory fitness in children and adolescents with post-infectious bronchiolitis obliterans: a randomised controlled trialRespiratory · Respir Med · 2026-10-07
Meta-analysisn = 13 trials
Cunha et al. The effects of exercise on pulmonary function and respiratory muscle strength in patients with chronic kidney disease: a systematic review and meta-analysisRespiratory · Am J Respir Crit Care Med · 2026-10-01
Guideline
McGraw et al. An update to the classification, evaluation, and management of childhood interstitial lung disease in infancy: an official American Thoracic Society Clinical Practice GuidelineRespiratory · Am J Respir Crit Care Med · 2026-10-01
RCTn = 106
Fujimoto et al. Three versus six weeks of corticosteroids for mild immune-related pneumonitis: a randomized trialRespiratory · Eur Respir J · 2026-09-25
Guideline
Bintalib et al. Clinical practice guideline for the diagnosis of granulomatous-lymphocytic interstitial lung disease in patients with common variable immunodeficiency disorders: an ERS Clinical Research CollaborationRespiratory · Eur Respir Rev · 2026-09-09
Meta-analysisn = 606,398
Leong et al. Comorbidities in clinical cohorts of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysisRespiratory · Eur Respir Rev · 2026-09-09
Meta-analysisn = 365,000
Satia et al. Normal age-related decline in forced vital capacity: a systematic review and meta-analysisRespiratory · Ann Am Thorac Soc · 2026-09-01
RCTn = 172
Kaburaki et al. Low-dose vs standard-dose nintedanib at initiation in fibrosing interstitial lung disease: a target-trial emulation of treatment persistence and lung functionRespiratory · Am J Respir Crit Care Med · 2026-08-01
RCTn = 243
Okuda et al. Pamufetinib (TAS-115) for chronic fibrosing interstitial lung diseases with a progressive phenotype: a double-blind, multicenter, phase 2b clinical trialRespiratory · Am J Respir Crit Care Med · 2026-08-01
RCTn = 257
Maher et al. Deupirfenidone compared with pirfenidone and placebo in idiopathic pulmonary fibrosis (ELEVATE-IPF): a phase 2b randomized placebo-controlled trialRespiratory · Ann Am Thorac Soc · 2026-08-01
Meta-analysisn = 31,739
Chae et al. Age-, sex-, and smoking-specific prevalence and progression in interstitial lung abnormality: patient-level meta-analysisRespiratory · Respir Res · 2026-07-15
Secondary analysisn = 392
Maher et al. Biomarker profiles in idiopathic and progressive pulmonary fibrosis after LPA1 antagonism: exploratory analysis from a phase 2 trial of admilparantRespiratory · Eur Respir J · 2026-07-09
RCTn = 1,176
Wijsenbeek et al. Nerandomilast in progressive pulmonary fibrosis: data from the whole follow-up period of the FIBRONEER-ILD trialRespiratory · Eur Respir J · 2026-07-09
RCTn = 107
Van Den Blink et al. Safety and efficacy of namilumab for the treatment of chronic pulmonary sarcoidosis (RESOLVE-Lung): a randomised, double-blinded, multicentre, phase 2 studyRespiratory · Respirology · 2026-07-07
RCTn = 101
Smallwood et al. The SINFONIA Study: A Randomised Controlled Trial to Determine Feasibility and Effectiveness of Online Group Singing for People With COPD or ILD and BreathlessnessRespiratory · Respir Med · 2026-06-06
RCTn = 116
Xiao et al. The clinical efficacy of hydrogen combined with tetrandrine in the treatment of silicosis fibrosis: A randomized controlled intervention studyRespiratory · N Engl J Med · 2026-05-18
RCTn = 598
Nathan et al. Phase 3 Trials of Inhaled Treprostinil for Idiopathic Pulmonary FibrosisRespiratory · Respir Med · 2026-05-16
Meta-analysisn = 6,093
Hashim et al. Prevalence of relapse in pulmonary sarcoidosis: A systematic review and meta-analysisRespiratory · Eur Respir Rev · 2026-05-13
Meta-analysisn = 143 studies
Mor et al. Yield and safety of different biopsy types in interstitial lung disease: a systematic review and meta-analysis